Investors.salariuspharma.com

  1. Home
  2. Investors.salariuspharma.com

Salarius Pharmaceuticals Adds Two Mayo Clinic Sites to its …

WebExpands Trial to 17 U.S. Sites and 25 Locations Initiation of All Anticipated U.S. Trial Sites Largely Completed. HOUSTON, Aug. 22, 2022 (GLOBE NEWSWIRE) -- …

Actived: 5 days ago

URL: https://investors.salariuspharma.com/news-releases/news-release-details/salarius-pharmaceuticals-adds-two-mayo-clinic-sites-its-ongoing

Salarius Pharmaceuticals and Fox Chase Cancer Center Launch …

WebHOUSTON, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new …

Category:  Health Go Health

Salarius Pharmaceuticals and Nationwide Children’s Hospital …

WebHOUSTON, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines …

Category:  Medicine Go Health

Salarius Pharmaceuticals and Nationwide Children’s Hospital …

WebHOUSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new …

Category:  Health Go Health

Salarius Pharmaceuticals Adds Fox Chase Cancer Center to …

WebClinical Trial Now Expands to Nine U.S. Trial Sites. HOUSTON, July 13, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage …

Category:  Health Go Health

Salarius Pharmaceuticals Announces Interim Results from Phase …

Web60% Confirmed Disease Control Rate 1 and 7.4 Months Median Time to Tumor Progression for Ewing Sarcoma First-Relapse Patients. No Disease Progression …

Category:  Health Go Health

Salarius Pharmaceuticals Adds Seattle Cancer Care Alliance and …

WebClinical Trial Now Expands to Fifteen U.S. Trial Sites. HOUSTON, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a …

Category:  Health Go Health

Salarius Pharmaceuticals Adds Memorial Sloan Kettering Cancer …

WebSalarius Targeting Key Safety and Efficacy Data Milestones in 2020 HOUSTON, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical …

Category:  Health Go Health

FDA Removes Partial Clinical Hold on Salarius Pharmaceuticals’ …

WebDecision Follows Review of Comprehensive Safety Data Package Submitted by the Company. Salarius Plans to Meet with FDA to Discuss Future Development and …

Category:  Health Go Health

Salarius Pharmaceuticals Names Nadeem Mirza, M.D., M.P.H., as …

WebThe Investor Relations website contains information about Salarius Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial …

Category:  Health Go Health

Salarius Pharmaceuticals CEO Issues Letter to Stockholders

WebHOUSTON, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing medicines for …

Category:  Medicine Go Health

IN THE NEWS Salarius Pharmaceuticals, Inc.

WebSalarius, Aspire Capital announce a $10.9M stock purchase agreement. Houston Business Journal.

Category:  Health Go Health

Salarius Pharmaceuticals Hosting Key Opinion Leader Call on …

WebHOUSTON, Dec. 17, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of …

Category:  Health Go Health

Salarius Pharmaceuticals Reports Second Quarter 2022 Financial …

WebThree Months Ended June 30 Six Months Ended June 30 2022 2021 2022 2021 Revenue: Grant revenue $ — $ 571,387

Category:  Health Go Health

investors.salariuspharma.com

WebTable of Contents. UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. FORM 10-Q/A. Amendment No. 1 (Mark One) QUARTERLY …

Category:  Health Go Health

investors.salariuspharma.com

WebSecurities registered pursuant to Section 12(g) of the Act: None. Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securitie

Category:  Health Go Health

investors.salariuspharma.com

WebThe Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it. is accurate and complete.

Category:  Health Go Health

SEC Filing Salarius Pharmaceuticals, Inc.

WebThe information in Item 8.01 of this Current Report on Form 8-K/A, including in the sections entitled “Business,” and “Management’s Discussion and Analysis of Financial Condition …

Category:  Health Go Health

2014.10.06 Flex Management team FINAL

WebRod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chairman and Chief Executive …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Granite mesa health center marble

 › Health care proxy form alabama

 › Staines health group sign in

 › Staines health group registration

 › Financial health ratios meaning

 › Staines health centre email

 › Restorer home health services llc

 › Course overview community health nursing

 › Atlantic health system mychart

 › Granite mesa health center rehab

Recently Searched

 › Fedhealth family room sign in

 › Health insurance for poor women

 › Cone health dnp fellowship

 › Mychart memorial healthcare system

 › Gallup health care trends

 › Preventative health measures for children

 › Free health screening survey template

 › Why are health screenings important

 › Indiana university student health services

 › Women's health at bayonne